TP53INP2 and head and neck squamous cell carcinoma: In a recent study, Cao et al. [55] observed that lower TP53INP2 expression in head and neck squamous cell carcinoma (HNSCC) patients compared to normal controls, whereas patients with higher TP53INP2 expression exhibited longer survival times.